Showing results (291-300 of 338) with videos related to
Sort By:
Pageof 34
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Sex hormone status may modulate rate of expansion of proximal femur diameter in older women alongside other skeletal regulatorsS Kaptoge, N Dalzell, E Folkerd, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 29, 2000
Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study GroupA A Ismail, T W O'Neill, W Cockerill, et al.Acta Endocrinologica|December 1, 1982
Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferolJ Reeve, M Tellez, J R Green, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Quality of life as outcome in the treatment of osteoporosis: the development of a questionnaire for quality of life by the European Foundation for OsteoporosisP Lips, C Cooper, D Agnusdei, et al.Calcified Tissue International|March 1, 1996
Radial cortical and trabecular bone densities of men and women standardized with the European Forearm PhantomJ Reeve, H Kröger, J Nijs, et al.Science (New York, N.Y.)|May 23, 2002
A heat-sensitive TRP channel expressed in keratinocytesAndrea M Peier, Alison J Reeve, David A Andersson, et al.Journal of Medicinal Chemistry|May 16, 2003
Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognitionMark S Chambers, John R Atack, Howard B Broughton, et al.British Medical Journal|June 7, 1980
Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trialJ Reeve, P J Meunier, J A Parsons, et al.Journal of Medicinal Chemistry|March 3, 1999
Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptorF Sternfeld, A R Guiblin, R A Jelley, et al.QJM : Monthly Journal of the Association of Physicians|May 14, 1998
Management of male osteoporosis: report of the UK Consensus GroupR Eastell, I T Boyle, J Compston, et al.Pageof 34